RPRX logo

Royalty Pharma plc (RPRX) Cash From Investing

Annual CFI:

-$2.70B-$592.43M(-28.15%)
December 31, 2024

Summary

  • As of today, RPRX annual cash from investing is -$2.70 billion, with the most recent change of -$592.43 million (-28.15%) on December 31, 2024.
  • During the last 3 years, RPRX annual cash from investing has fallen by -$870.06 million (-47.63%).
  • RPRX annual cash from investing is now -988.74% below its all-time high of $303.42 million, reached on December 31, 2018.

Performance

1-Year Change

-28.15%

3-Year Change

-47.63%

5-Year Change

-27.43%

15-Year Change

-69.85%

RPRX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

2.09%
RPRX annual cash from investing is higher than 2.09% of companies in Healthcare sector

Range

All-Time High

$303.42M
RPRX annual cash from investing is currently -988.74% below its historical high of $303.42 million

3-Year Low

-$2.70B
RPRX annual cash from investing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RPRX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RPRX next annual earnings announcement has not yet been scheduled

OtherRPRXcash flow metrics

Annual CFF

$356.04M
RPRX annual cash from financing is $356.04 million

Annual CFO

$2.79B
RPRX annual cash from operations is $2.79 billion

Annual FCF

$268.93M
RPRX annual free cash flow is $268.93 million

Annual CAPEX

$2.52B
RPRX annual capital expenditures is $2.52 billion

Quarterly CFI:

-$311.98M-$815.90M(-161.91%)
June 30, 2025

Summary

  • As of today, RPRX quarterly cash from investing is -$311.98 million, with the most recent change of -$815.90 million (-161.91%) on June 30, 2025.
  • Over the past year, RPRX quarterly cash from investing has increased by +$581.19 million (+65.07%).
  • RPRX quarterly cash from investing is now -161.91% below its all-time high of $503.92 million, reached on March 31, 2025.

Performance

3-Month Change

-161.91%

1-Year Change

+65.07%

3-Year Change

-933.81%

5-Year Change

-27.36%

RPRX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

2.94%
RPRX quarterly cash from investing is higher than 2.94% of companies in Healthcare sector

Range

All-Time High

$503.92M
RPRX quarterly cash from investing is currently -161.91% below its historical high of $503.92 million

3-Year Low

-$1.43B
RPRX quarterly cash from investing is currently +78.11% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
RPRX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
RPRX next earnings announcement is scheduled for Nov 5, 2025

OtherRPRXcash flow metrics

Quarterly CFF

-$507.81M
RPRX quarterly cash from financing is -$507.81 million

Quarterly CFO

$363.98M
RPRX quarterly cash from operations is $363.98 million

Quarterly FCF

$363.98M
RPRX quarterly free cash flow is $363.98 million

Quarterly CAPEX

$1.11M
RPRX quarterly capital expenditures is $1.11 million

TTM CFI:

-$1.51B+$581.19M(+27.84%)
June 30, 2025

Summary

  • As of today, RPRX TTM cash from investing is -$1.51 billion, with the most recent change of +$581.19 million (+27.84%) on June 30, 2025.
  • Over the past year, RPRX TTM cash from investing has increased by +$924.30 million (+38.03%).
  • RPRX TTM cash from investing is now -128.97% below its all-time high of -$657.88 million, reached on September 30, 2023.

Performance

3-Month Change

+27.84%

1-Year Change

+38.03%

3-Year Change

-6.37%

5-Year Change

+24.29%

RPRX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

3.03%
RPRX TTM cash from investing is higher than 3.03% of companies in Healthcare sector

Range

All-Time High

-$657.88M
RPRX TTM cash from investing is currently -128.97% below its historical high of -$657.88 million

3-Year Low

-$3.17B
RPRX TTM cash from investing is currently +52.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
RPRX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
RPRX next earnings announcement is scheduled for Nov 5, 2025

OtherRPRXcash flow metrics

TTM CFF

-$2.03B
RPRX TTM cash from financing is -$2.03 billion

TTM CFO

$2.41B
RPRX TTM cash from operations is $2.41 billion

TTM FCF

$2.41B
RPRX TTM free cash flow is $2.41 billion

TTM CAPEX

$1.69B
RPRX TTM capital expenditures is $1.69 billion

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

RPRX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-28.1%+65.1%+38.0%
3Y3 Years-47.6%-933.8%-6.4%
5Y5 Years-27.4%-27.4%+24.3%

RPRX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-163.8%at low-161.9%+78.1%-129.0%+52.5%
5Y5-Year-163.8%+0.4%-161.9%+78.1%-129.0%+52.5%
All-TimeAll-Time-988.7%+0.4%-161.9%+78.1%-129.0%+52.5%

RPRX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$311.98M(-161.9%)
-$1.51B(+27.8%)
Mar 2025
-
$503.92M(+199.7%)
-$2.09B(+22.1%)
Dec 2024
-$2.70B(-28.2%)
-$505.59M(+57.6%)
-$2.68B(+15.6%)
Sep 2024
-
-$1.19B(-33.5%)
-$3.17B(-30.5%)
Jun 2024
-
-$893.18M(-930.8%)
-$2.43B(-51.8%)
Mar 2024
-
-$86.65M(+91.3%)
-$1.60B(+22.8%)
Dec 2023
-$2.10B(-105.8%)
-$1.00B(-121.9%)
-$2.07B(-215.1%)
Sep 2023
-
-$450.66M(-610.4%)
-$657.88M(+59.7%)
Jun 2023
-
-$63.43M(+88.6%)
-$1.63B(-2.1%)
Mar 2023
-
-$558.53M(-234.7%)
-$1.60B(-55.3%)
Dec 2022
-$1.02B(+44.0%)
$414.74M(+129.1%)
-$1.03B(+48.4%)
Sep 2022
-
-$1.43B(-4622.5%)
-$2.00B(-40.9%)
Jun 2022
-
-$30.18M(-370.3%)
-$1.42B(-12.4%)
Mar 2022
-
$11.16M(+102.0%)
-$1.26B(+32.6%)
Dec 2021
-$1.83B
-$551.65M(+34.8%)
-$1.87B(+13.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$845.50M(-770.1%)
-$2.15B(+3.4%)
Jun 2021
-
$126.17M(+121.1%)
-$2.23B(+14.3%)
Mar 2021
-
-$599.30M(+28.0%)
-$2.60B(+5.9%)
Dec 2020
-$2.71B(-27.9%)
-$832.40M(+9.5%)
-$2.76B(-38.7%)
Sep 2020
-
-$920.20M(-275.6%)
-$1.99B(-18.1%)
Jun 2020
-
-$244.97M(+67.8%)
-$1.68B(-5.4%)
Mar 2020
-
-$761.75M(-1112.7%)
-$1.60B(+25.8%)
Dec 2019
-$2.12B(-797.4%)
-$62.82M(+89.8%)
-$2.15B(-3.0%)
Sep 2019
-
-$615.27M(-288.5%)
-$2.09B(-41.7%)
Jun 2019
-
-$158.37M(+88.0%)
-$1.48B(-12.0%)
Mar 2019
-
-$1.32B
-$1.32B
Dec 2018
$303.42M(+119.1%)
-
-
Dec 2017
-$1.59B(-162.0%)
-
-
Dec 2016
-$605.93M(-1042.5%)
-
-
Dec 2015
$64.29M
-
-

FAQ

  • What is Royalty Pharma plc annual cash from investing?
  • What is the all-time high annual cash from investing for Royalty Pharma plc?
  • What is Royalty Pharma plc annual cash from investing year-on-year change?
  • What is Royalty Pharma plc quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly cash from investing year-on-year change?
  • What is Royalty Pharma plc TTM cash from investing?
  • What is the all-time high TTM cash from investing for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM cash from investing year-on-year change?

What is Royalty Pharma plc annual cash from investing?

The current annual cash from investing of RPRX is -$2.70B

What is the all-time high annual cash from investing for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cash from investing is $303.42M

What is Royalty Pharma plc annual cash from investing year-on-year change?

Over the past year, RPRX annual cash from investing has changed by -$592.43M (-28.15%)

What is Royalty Pharma plc quarterly cash from investing?

The current quarterly cash from investing of RPRX is -$311.98M

What is the all-time high quarterly cash from investing for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cash from investing is $503.92M

What is Royalty Pharma plc quarterly cash from investing year-on-year change?

Over the past year, RPRX quarterly cash from investing has changed by +$581.19M (+65.07%)

What is Royalty Pharma plc TTM cash from investing?

The current TTM cash from investing of RPRX is -$1.51B

What is the all-time high TTM cash from investing for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cash from investing is -$657.88M

What is Royalty Pharma plc TTM cash from investing year-on-year change?

Over the past year, RPRX TTM cash from investing has changed by +$924.30M (+38.03%)
On this page